Name | Synonyms | Targets | Target Pathway | PubCHEM | Datatset | Sample size | Screening site |
---|---|---|---|---|---|---|---|
BDOCA000347a | 4-bromo-N-(6-methoxy-1,3-dimethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)-2-methylbenzenesulfonamide | BRPF1, BRPF2, BRPF3 | Chromatin histone acetylation | GDSC2 | 717 | SANGER | |
Bromosporine | ethyl N-[6-(3-methanesulfonamido-4-methylphenyl)-3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-8-yl]carbamate | CECR2, BRD2, BRD4, BRD9 | Chromatin other | GDSC2 | 716 | SANGER | |
FTI-277 | Farnesyl-transferase (FNTA) | Other | 3005532 | GDSC1 | 880 | MGH | |
Ispinesib Mesylate | SB-715992 | KSP | Mitosis | 6450816 | GDSC1 | 911 | MGH |
Luminespib | AUY922, VER-52296,NVP-AUY922, AUY | HSP90 | Protein stability and degradation | 10096043 | GDSC1 | 862 | MGH |
Luminespib | AUY922, VER-52296,NVP-AUY922, AUY | HSP90 | Protein stability and degradation | 10096043 | GDSC2 | 964 | SANGER |
Tanespimycin | 17-AAG, BMS-722782 | HSP90 | Protein stability and degradation | 6505803 | GDSC1 | 930 | SANGER |
Tanespimycin | 17-AAG, BMS-722782 | HSP90 | Protein stability and degradation | 6505803 | GDSC2 | 949 | SANGER |
Tipifarnib | Zarnestra | Farnesyl-transferase (FNTA) | Other | 159324 | GDSC1 | 871 | MGH |
Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.